Search Results
A key take-home message from the EBMT-EHA CAR T-Cell Meeting
The role of the EBMT regarding CAR T-cell therapy
What to expect at the upcoming EMBT-EHA CAR-T Meeting
Processes in CAR T-cell Therapy
How can HCPs and organizations help involve patients undergoing CAR T-cell therapy
Patient perspectives of CAR T-cell therapy
Cami-T in R/R cHL: analysis of clinical determinants of safety and efficacy
UK real-world CD19 CAR-T data - thoughts from Graham Collins
IACH Post EBMT 2024
Update on bb2121 CAR T-cell product for MM from EHA 2018
Prof. Philip McCarthy | ASH 17 | Take home messages for transplant-eligible MM patients
MACRO - Presentation at EBMT 2018 Lisbon
